Geron’s blood cancer drug succeeds in late-stage study, shares surge
Geron’s drug, imetelstat, was being studied in patients with a type of myelodysplastic syndromes (MDS), a difficult-to-treat…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.